"With the global stem cell market expanding, we see an opportunity to make these treatments more accessible in the U.S.," ...

Danés, principal investigator of the Cancer and Stem Cell Biology Lab at the Champalimaud Foundation, in Lisbon, has shown ...

In a clinical trial, patients treated with a kidney cancer vaccine remained cancer-free after a median of nearly three years.

ADIA Nutrition Inc. (OTC Pink: ADIA), a leader in health and wellness solutions, has uncovered issues with share issuance ...

Dr. Tycel Phillips discusses the implications of the FDA approval of Calquence plus bendamustine and Rituxan in untreated MCL ...

Scientists at The Hospital for Sick Children (SickKids) have discovered a way to stop tumor growth before it starts for a ...

A novel drug regimen tested for the first time by researchers at Fred Hutch Cancer Center has shown great promise in ...

Stem cell therapy has come a long way since its early days. As an athlete who has undergone it twice, I know that the ...

All treated AML patients in both the original and expansion cohorts through January 17, 2025 remain in complete remission. The original cohort of AML patients has reached a median CR of 23.3 months, ...

Bone-marrow-derived multipotent progenitor stromal cells — or mesenchymal stem cells (MSCs ... proliferation through the induction of cell-division arrest, which is enhanced by interferon ...

A "courageous and brave" rugby player has died aged 27 after being diagnosed with leukaemia a year ago. Ellis Joseph's former ...